Literature DB >> 15259462

Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon.

R P Almeida Cunha1, F P Alves, A M C Rocha, G A Rocha, L M A Camargo, P O P Nogueira, E P Camargo, D M M Queiroz.   

Abstract

We evaluated the prevalence of, and factors associated with, Helicobacter pylori infection in 222 subjects from 3 distinct communities of native populations (Uru-Eu-Wau-Wau Indians and 2 riverine communities living on the banks of the Machado river and in Portuchuelo) living in isolation in the rainforest of Brazilian Western Amazon. The overall prevalence was 78.8% (95% CI 72.7-83.9). The prevalence was higher in the Machado river community compared with Portuchuelo (chi2 = 3.84, P = 0.05), but no significant difference was observed between the Machado river community and the Uru-Eu-Wau-Wau Indians. Logistic regression showed that residential crowding and age were factors associated with the presence of H. pylori infection. Acquisition of the bacterium started early in life and by the age of 2 years 50% of children were infected. The prevalence increased with age, reaching near universal levels during adulthood (97.9%). Residential crowding was high with a global index of 3.3 persons/room (SD = 1.8), varying significantly between the 3 communities (P = 0.001). These data provide further evidence supporting direct person-to-person spread of the bacterium.

Entities:  

Mesh:

Year:  2003        PMID: 15259462     DOI: 10.1016/s0035-9203(03)90063-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.

Authors:  Luiz E Mazzoleni; Guilherme B Sander; Eduardo A Ott; Sérgio G S Barros; Carlos F Francesconi; Carisi A Polanczyk; André C Wortmann; Alexandro L Theil; Leandro G Fritscher; Luis F Rivero; André Cartell; Maria I A Edelweiss; Diego M Uchôa; João C Prolla
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial.

Authors:  Mohammed Q Khan
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

3.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

4.  Different risk factors influence peptic ulcer disease development in a Brazilian population.

Authors:  Rodrigo Buzinaro Suzuki; Rodrigo Faria Cola; Larissa Tranquilino Bardela Cola; Camila Garcia Ferrari; Fred Ellinger; Altino Luiz Therezo; Luis Carlos Silva; André Eterovic; Márcia Aparecida Sperança
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

5.  Prevalence of Helicobacter pylori infection and associated factors among adults in Southern Brazil: a population-based cross-sectional study.

Authors:  Ina S Santos; Jose Boccio; Ari S Santos; Neiva C J Valle; Camila S Halal; Marta Colvara Bachilli; Ricardo D Lopes
Journal:  BMC Public Health       Date:  2005-11-10       Impact factor: 3.295

6.  Magnitude of Helicobacter pylori and associated risk factors among symptomatic patients attending at Jasmin internal medicine and pediatrics specialized private clinic in Addis Ababa city, Ethiopia.

Authors:  Gemechu Shiferaw; Dessie Abera
Journal:  BMC Infect Dis       Date:  2019-02-06       Impact factor: 3.090

7.  Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Tomás Navarro-Rodriguez; Fernando Marcuz Silva; Ricardo Correa Barbuti; Rejane Mattar; Joaquim Prado Moraes-Filho; Maricê Nogueira de Oliveira; Cristina S Bogsan; Décio Chinzon; Jaime Natan Eisig
Journal:  BMC Gastroenterol       Date:  2013-03-26       Impact factor: 3.067

8.  Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.

Authors:  Fernando M Silva; Jaime N Eisig; Ana Cristina S Teixeira; Ricardo C Barbuti; Tomás Navarro-Rodriguez; Rejane Mattar
Journal:  BMC Gastroenterol       Date:  2008-05-29       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.